The Week in Review: ChinaBio® Partnering Forum

Representatives of 337 companies from 23 countries attended the successful Second Annual ChinaBio® Partnering Forum 2010 in Suzhou, China; Fountain Medical Development and ICON plc will jointly operate a central lab facility in Tianjin; Zhejiang Huahai Pharma will spin off its US generic drug business; China PharmaHub set up a JV built around new technology for humanizing antibodies; NeoStem raised $5 million in a private placement; ULURU out-licensed the China rights for its wound healing product to Jiangxi Aiqilin Pharma; and China Nuokang Bio-Pharmaceutical struck a deal to register and distribute Dianatal® Obstetric Gel in China. More details... Stock Symbols: (NSDQ: ICLR) (SHEX: 600521) (NYSE Amex: NBS) (NYSE Alternext: ULU) (NSDQ: NKBP)